Profile data is unavailable for this security.
About the company
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
- Revenue in JPY (TTM)2.83tn
- Net income in JPY31.84bn
- Incorporated2003
- Employees11.77k
- LocationAlfresa Holdings Corp23F, Ote Center Bldg., 1-1-3, Ote-machiCHIYODA-KU 100-0004JapanJPN
- Phone+81 352195100
- Fax+81 352195103
- Websitehttps://www.alfresa.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 23.71bn | -6.92bn | 268.28bn | 1.95k | -- | 7.28 | -- | 11.32 | -0.6628 | -0.6628 | 2.27 | 3.53 | 0.4005 | 0.8061 | 1.31 | 569,846.60 | -12.26 | -1.17 | -16.80 | -1.67 | 69.24 | 71.94 | -30.62 | -3.27 | 1.55 | -18.71 | 0.1474 | -- | 16.44 | -3.17 | -26.08 | -- | -50.29 | -- |
| Toho Holdings Co Ltd | 1.45tn | 17.57bn | 298.39bn | 7.70k | 16.13 | 1.02 | 12.32 | 0.2057 | 242.08 | 242.08 | 20,008.50 | 3,831.19 | 1.81 | 14.05 | 4.05 | 188,375,100.00 | 2.20 | 1.83 | 6.09 | 4.35 | 7.94 | 8.60 | 1.21 | 0.9786 | 1.05 | -- | 0.1298 | 18.14 | 9.67 | 2.73 | 1.88 | -1.07 | -22.49 | 1.30 |
| China Medical System Holdings Ltd | 170.99bn | 51.23bn | 338.99bn | 5.70k | 6.62 | 1.02 | 6.08 | 1.98 | 1.06 | 1.06 | 3.53 | 6.84 | 0.4517 | 3.42 | 6.19 | 1,518,854.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| China Meheco Group Co Ltd | 863.45bn | 12.01bn | 354.88bn | 8.31k | 29.54 | 1.49 | -- | 0.411 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
| Suzuken Co Ltd | 2.37tn | 27.68bn | 368.34bn | 13.43k | 14.06 | 0.9048 | 10.13 | 0.1553 | 336.97 | 336.97 | 28,802.96 | 5,236.47 | 1.82 | 12.94 | 4.05 | 176,574,900.00 | 2.12 | 1.77 | 6.33 | 4.64 | 7.75 | 8.05 | 1.17 | 0.9199 | 0.9883 | -- | 0.00 | 31.44 | 3.38 | 1.74 | 41.35 | 1.57 | 17.43 | 5.92 |
| Alfresa Holdings Corporation | 2.83tn | 31.84bn | 476.78bn | 11.77k | 14.41 | 0.9466 | 10.52 | 0.1686 | 163.14 | 163.14 | 14,454.60 | 2,483.23 | 1.92 | 15.08 | 4.12 | 240,225,700.00 | 2.17 | 2.47 | 6.17 | 6.52 | 7.24 | 7.34 | 1.13 | 1.24 | 1.03 | -- | 0.0607 | 33.25 | 4.27 | 0.7057 | -19.87 | -6.24 | 15.54 | 7.89 |
| Medipal Holdings Corp | 3.51tn | 37.24bn | 550.68bn | 12.80k | 14.15 | 0.9012 | 8.46 | 0.157 | 175.85 | 175.85 | 16,560.73 | 2,761.44 | 1.91 | 16.34 | 4.40 | 274,130,900.00 | 2.60 | 2.62 | 7.75 | 7.32 | 6.85 | 6.90 | 1.37 | 1.34 | 1.01 | -- | 0.00 | 27.22 | 2.10 | 1.32 | 31.89 | 2.21 | -15.04 | 6.23 |
| China National Medicines Corp Ltd | 1.08tn | 46.74bn | 559.37bn | 3.14k | 11.97 | 1.62 | -- | 0.5182 | 2.90 | 2.90 | 67.05 | 21.51 | 1.61 | 11.21 | 6.58 | 16,122,340.00 | 7.57 | 7.32 | 14.41 | 15.03 | 7.63 | 8.15 | 4.70 | 4.31 | 1.77 | -- | 0.1271 | 30.04 | 9.23 | 5.11 | 9.26 | 8.85 | 1.84 | 16.38 |
| EBOS Group Ltd | 1.28tn | 25.92bn | 619.41bn | 5.20k | 23.69 | 2.58 | 15.20 | 0.4853 | 1.48 | 1.48 | 72.47 | 13.56 | 1.90 | 8.79 | 8.35 | 2,681,029.00 | 3.94 | 4.32 | 6.35 | 7.62 | 12.49 | 11.47 | 2.08 | 1.98 | 0.7358 | 6.79 | 0.4402 | 76.77 | 14.00 | 11.86 | 25.06 | 13.04 | 11.11 | 10.05 |
| China Resources Pharmaceutical Group Ltd | 5.22tn | 82.24bn | 629.43bn | 72.99k | 7.65 | 0.6418 | 2.70 | 0.1205 | 0.6629 | 0.6629 | 42.09 | 7.90 | 1.06 | 7.06 | 3.84 | 3,622,912.00 | 3.36 | 3.02 | 12.72 | 11.35 | 15.67 | 15.72 | 3.18 | 2.87 | 1.09 | 8.70 | 0.412 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
| Jointown Pharmaceutical Group Co Ltd | 3.17tn | 46.26bn | 684.67bn | 30.10k | 15.01 | 1.31 | -- | 0.2161 | 0.5469 | 0.5469 | 37.57 | 6.28 | 1.53 | 8.05 | 3.96 | 4,934,201.00 | 2.31 | 3.01 | 7.85 | 9.72 | 7.68 | 8.24 | 1.50 | 1.98 | 0.9782 | 3.50 | 0.5673 | 34.73 | 6.92 | 11.50 | 4.88 | 14.16 | -10.39 | 39.14 |
Data as of May 02 2024. Currency figures normalised to Alfresa Holdings Corp's reporting currency: Japanese Yen JPY
24.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 14 Nov 2023 | 20.91m | 10.31% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 7.22m | 3.56% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 5.70m | 2.81% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 3.23m | 1.59% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 3.15m | 1.55% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.58m | 1.27% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 2.06m | 1.01% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 11 Mar 2024 | 1.72m | 0.85% |
| Geode Capital Management LLCas of 29 Feb 2024 | 1.43m | 0.71% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 1.41m | 0.70% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
